The iFuse Implant System is a minimally invasive surgical system made up of titanium implants covered in a porous plasma spray that works as an interference surface fit to help decrease implant motion, according to the release.
SI-BONE received FDA clearance for the iFuse system in Nov. 2008 and anticipates CE Mark certification in Europe. US surgeons are preparing to present initial clinical data at spine meetings this fall, according to the release.
Read the news release on SI-BONE iFuse implant system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
